Trudi McDevitt

1.1k total citations
19 papers, 750 citations indexed

About

Trudi McDevitt is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Trudi McDevitt has authored 19 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Trudi McDevitt's work include BRCA gene mutations in cancer (8 papers), Genomic variations and chromosomal abnormalities (5 papers) and Genomics and Rare Diseases (3 papers). Trudi McDevitt is often cited by papers focused on BRCA gene mutations in cancer (8 papers), Genomic variations and chromosomal abnormalities (5 papers) and Genomics and Rare Diseases (3 papers). Trudi McDevitt collaborates with scholars based in Ireland, United Kingdom and United States. Trudi McDevitt's co-authors include Michael J. Tisdale, Peter Cariuk, Kenneth C.H. Fearon, Penio Todorov, Brian Coles, P T Todorov, M J Tisdale, I Ohkubo, H. Ueyama and David J. Meyer and has published in prestigious journals such as Nature, The American Journal of Human Genetics and Annals of Oncology.

In The Last Decade

Trudi McDevitt

18 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trudi McDevitt Ireland 11 378 339 131 127 100 19 750
Isabel Castro Chile 16 530 1.4× 343 1.0× 70 0.5× 104 0.8× 32 0.3× 32 822
Godfrey T. Gillett United Kingdom 13 190 0.5× 286 0.8× 33 0.3× 138 1.1× 138 1.4× 20 677
Melker Göransson Sweden 12 173 0.5× 410 1.2× 78 0.6× 37 0.3× 43 0.4× 14 673
Yuan-Yuan Ho Hong Kong 12 103 0.3× 325 1.0× 86 0.7× 275 2.2× 24 0.2× 18 785
Misako Kawahara United States 9 270 0.7× 258 0.8× 67 0.5× 64 0.5× 17 0.2× 9 583
Penio Todorov United Kingdom 8 268 0.7× 290 0.9× 66 0.5× 24 0.2× 76 0.8× 8 597
Nadine Wiper‐Bergeron Canada 14 207 0.5× 489 1.4× 63 0.5× 67 0.5× 13 0.1× 25 662
Joanna R. DiSpirito United States 12 256 0.7× 388 1.1× 81 0.6× 82 0.6× 17 0.2× 14 1.0k
Angelika Jurdzinski Netherlands 10 73 0.2× 323 1.0× 140 1.1× 49 0.4× 34 0.3× 19 598
Nandita S. Raikwar United States 17 55 0.1× 333 1.0× 77 0.6× 65 0.5× 30 0.3× 27 620

Countries citing papers authored by Trudi McDevitt

Since Specialization
Citations

This map shows the geographic impact of Trudi McDevitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trudi McDevitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trudi McDevitt more than expected).

Fields of papers citing papers by Trudi McDevitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trudi McDevitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trudi McDevitt. The network helps show where Trudi McDevitt may publish in the future.

Co-authorship network of co-authors of Trudi McDevitt

This figure shows the co-authorship network connecting the top 25 collaborators of Trudi McDevitt. A scholar is included among the top collaborators of Trudi McDevitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trudi McDevitt. Trudi McDevitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rowlands, Charlie F, Alice Garrett, Miranda Durkie, et al.. (2025). Availability of benign missense variant “truthsets” for validation of functional assays: Current status and a systematic approach. The American Journal of Human Genetics. 112(10). 2281–2294.
2.
Rowlands, Charlie F, Alice Garrett, Miranda Durkie, et al.. (2024). The PS4-likelihood ratio calculator: flexible allocation of evidence weighting for case-control data in variant classification. Journal of Medical Genetics. 61(10). 983–991. 1 indexed citations
3.
4.
McDevitt, Trudi, Miranda Durkie, Norbert Arnold, et al.. (2024). EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer. European Journal of Human Genetics. 32(5). 479–488. 5 indexed citations
5.
McVeigh, Terri, Michael Farrell, Lisa Bradley, et al.. (2017). Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series. Cancer Genetics. 214-215. 1–8. 5 indexed citations
6.
7.
McDevitt, Trudi, Rui Martiniano, Russell L. McLaughlin, et al.. (2015). Detection of novel germline mutations for breast cancer in non‐BRCA1/2 families. FEBS Journal. 282(17). 3424–3437. 35 indexed citations
8.
McDevitt, Trudi, A. O’Doherty, Cecily Quinn, et al.. (2015). Phenotypic analysis of familial breast cancer: Comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer. European Journal of Surgical Oncology. 41(5). 641–646. 10 indexed citations
9.
McVeigh, Terri, Nicola Miller, Trudi McDevitt, et al.. (2013). Familial breast cancer genetic testing in the West of Ireland. Irish Journal of Medical Science (1971 -). 183(2). 199–206. 3 indexed citations
10.
Farrell, Michael, David J. Hughes, Ian Berry, et al.. (2012). Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome. Familial Cancer. 11(3). 509–518. 3 indexed citations
11.
Chen, Jian‐Min, Nadia Chuzhanova, Caroline Bénech, et al.. (2010). Complete ascertainment of intragenic copy number mutations (CNMs) in the CFTR gene and its implications for CNM formation at other autosomal loci. Human Mutation. 31(4). 421–428. 23 indexed citations
12.
Green, Andrew, et al.. (2008). Cascade screening in BRCA1/2 mutation carriers.. PubMed. 101(5). 140–2. 11 indexed citations
13.
Daly, Peter A., Andrew Green, W. Ormiston, et al.. (2003). Predictive testing for BRCA1 and 2 mutations: a male contribution. Annals of Oncology. 14(4). 549–553. 32 indexed citations
14.
Scotet, Virginie, David Barton, James Watson, et al.. (2003). Comparison of the CFTR mutation spectrum in three cohorts of patients of Celtic origin from Brittany (France) and Ireland. Human Mutation. 22(1). 105–105. 14 indexed citations
15.
Todorov, P T, Trudi McDevitt, David J. Meyer, et al.. (1998). Purification and characterization of a tumor lipid-mobilizing factor.. PubMed. 58(11). 2353–8. 141 indexed citations
16.
Todorov, Penio, Peter Cariuk, Trudi McDevitt, et al.. (1996). Characterization of a cancer cachectic factor. Nature. 379(6567). 739–742. 335 indexed citations
17.
Todorov, P T, et al.. (1996). Induction of muscle protein degradation and weight loss by a tumor product.. PubMed. 56(6). 1256–61. 68 indexed citations
18.
McDevitt, Trudi, et al.. (1995). Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans.. PubMed. 55(7). 1458–63. 35 indexed citations
19.
Cramb, Gordon, et al.. (1989). THE EFFECTS OF MONENSIN ON THE ABUNDANCE OF mRNA(α) AND OF SODIUM PUMPS IN HUMAN CULTURED CELLS. Quarterly Journal of Experimental Physiology. 74(1). 53–63. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabel Castro Breakdown of academic impact, for papers by Godfrey T. Gillett Breakdown of academic impact, for papers by Melker Göransson Breakdown of academic impact, for papers by Yuan-Yuan Ho Breakdown of academic impact, for papers by Misako Kawahara Breakdown of academic impact, for papers by Penio Todorov Breakdown of academic impact, for papers by Nadine Wiper‐Bergeron Breakdown of academic impact, for papers by Joanna R. DiSpirito Breakdown of academic impact, for papers by Angelika Jurdzinski Breakdown of academic impact, for papers by Nandita S. Raikwar
Rankless by CCL
2026